Alessandra Rusignuolo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Peripheral blood stem cells (PBSC) are widely used in the setting of dose-intensive chemotherapies in patients with multiple myeloma (MM). Although the granulocyte colony-stimulating factor (G-CSF), following chemotherapy or not, is considered the standard growth factor for mobilizing PBSC, the optimal chemotherapeutic regimen still remains to be defined.(More)
  • 1